MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Organization & Developments: Bay City
Parents
Bay City Capital
Children
2009: $50 million round of venture capital financing, led by Skyline Ventures and Frazier Healthcare Ventures. Bay City Capital and InterWest Partners (2009)
2011: Epocrates has raised more than $46 million from Bay City Capital, Draper Fisher Jurvetson, Hudson Street, Goldman Sachs Group Inc., InterWest Partners, Sprout Group and Three Arch Partners (2011)
2012: SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC (2012)
2014: Venture firms that still have a stake in Cadence include Domain Associates, Frazier Healthcare Ventures, Wellington Management, Versant Ventures, Bay City Capital, and NEA
BioSeek Completes $8.4 Million Series A Financing. The Series A round investors are Bay City Capital, Fremont Ventures, SImile Investors LLC and Vanguard V.
Existing investors participating in this financing round included Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital, and Three Arch Partners.
Founded and seed financed by former members of the Peplin and Connetics leadership teams, including Tom Wiggans, who will serve as Chief Executive Officer, and Dr. Eugene Bauer, who will serve as Chief Medical Officer, together with Bay City Capital
Investors in Dermira are Bay City Capital, New Enterprise Associates (NEA) and Canaan Partners
Investors include Bay City Capital, MedImmuneVentures, New Enterprise Associates, Oxford Bioscience Partners, Technology Partners, Pappas Ventures, NeuroVentures, Mitsubishi UFJ Capital, Mizuho, and Alexandria Real Estate Equities.
Investors: Bay City Capital
Merck Global Health Innovation Fund led the round. Current investors Bay City Capital, Aberdare Ventures, and New Leaf Venture Partners also participated.
Omicia has picked up a $6.8 million series A led by Artis Ventures, Buchannan Investments, Bay City Capital, as well as Acadia Woods Partners and Casdin Capital
Participants include Panorama Capital, Bay City Capital, Kearny Venture Partners, Aisling Capital, Fidelity Biosciences, Sofinnova Ventures and Vivo Ventures.
The financing also included strong support and additional investment from existing venture capital firms PTV Sciences, Bay City
The latest money came from AgeChem Venture Fund of Montreal, Aberdare Ventures of San Francisco, Advent Venture Partners of London, Bay City Capital of San Francisco, Gilde Healthcare Partners of the Netherlands, and Roche Venture Fund of Basel, Switzerlan
Jumps
*Key People: Bay City
Finance & Acquisition: Bay City